1 minute treatment update

Treatment pearls in your chosen speciality or topic, as they are published, updated every 48 hours.
Last updated on 2023/10/03.





Dermatol Surg 29 Sep. 2023.
Efficacy and Safety of Precision Cryotherapy to Treat Seborrheic Dermatitis of the Scalp.

This study not only demonstrated the efficacy and safety of PC in scalp SD but it also revealed insights for PC being a promising treatment modality in immune-related skin diseases.

 Pubmed Scholar sci-hub

J Urol 03 Oct. 2023.
Total Margin Control is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma.

Initial results are encouraging that PDEMA surgical management effectively controls early-stage penile squamous cell carcinoma.

 Pubmed Scholar sci-hub

Clin Rheumatol 03 Oct. 2023.
Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment.

In guselkumab-treated patients with active PsA, earlier improvement in joint symptoms significantly associated with lower RP rates through 2 years, indicating blockade of the IL-23 pathway may modify long-term disease course and prevent further joint damage. Key Points • Greater improvement in DAPSA at Week 8 of guselkumab treatment was significantly associated with less progression of structural joint damage at 2 years in patients with active psoriatic arthritis (PsA). • Early control of peripheral joint disease activity with blockade of the IL-23 pathway may modify long-term PsA trajectory and prevent further joint damage.

 Pubmed Scholar sci-hub

Acta Derm Venereol 03 Oct. 2023.
Disease Awareness and Treatment Preferences in Vitiligo: A Cross-sectional Study in China.

Insufficient knowledge was associated with a higher burden of disease. In order to reduce the disease burden and improve treatment adherence it is crucial to enhance disease awareness and take into account patient preferences

 Pubmed Scholar sci-hub

Pediatr Transplant 03 Oct. 2023.
Characterizing the cutaneous late effects of allogeneic hematopoietic stem cell transplantation: A systematic review.

Skin cancers are reported in pediatric allogeneic HSCT recipients, and the risk appears to be increased. More data are needed to better characterize this risk.

 Pubmed Scholar sci-hub

JAAD Int Dec. 2023.
Biologic therapy for refractory pemphigoid gestationis: An evidence-based systematic review.

Sorry! No treatment pearl could be fetched.

 Pubmed Scholar sci-hub

J Cosmet Dermatol 02 Oct. 2023.
Consensus recommendations on the use of injectable poly-l-lactic acid in Asian patients.

In the above consensus recommendations, the authors shared their best practices in accordance with the updated preparation and treatment protocols of PLLA. These recommendations represent the clinical and real-world techniques utilized by authors in providing PLLA treatments for Asian patients.

 Pubmed Scholar sci-hub

Int J Radiat Oncol Biol Phys 01 Oct. 2023.
Radiation Therapy Knowledge and Health Literacy among Culturally Diverse Patients with Prostate Cancer Treated at a Safety-Net Hospital.

There is a significant gap between perceived and measured knowledge of RT treatment and SE in patients who receive consultation for RT to the prostate gland/fossa. Health literacy was significantly associated with improved knowledge of RT and short-term SE. Spanish-speaking patients had poorer understanding of long-term SE than English-speaking patients. Efforts to identify gaps in patient health literacy are needed to target those at risk and ensure that culturally diverse patient populations can engage in shared decision making with their providers.

 Pubmed Scholar sci-hub

Int J Radiat Oncol Biol Phys 01 Oct. 2023.
Synergistic Effect of TVEC and Radiotherapy in the Treatment of Advanced Melanoma.

Comparing pts who had TVEC and RT to different regions of the body, there was an association with improvements in PFS and DM when both modalities were delivered to the same region of the body. However, we did not find a significant difference in locoregional recurrence or OS. Given some promise with the combined approach and potential immune enhancement from RT, larger trials are needed to better understand the potential positive signal from our study.

 Pubmed Scholar sci-hub

Int J Radiat Oncol Biol Phys 01 Oct. 2023.
Image-Guided Superficial Radiation Therapy Has Superior 2-Year Recurrence Rates to Mohs Micrographic Surgery.

In this analysis, IGSRT has superior 2-year recurrence rates. Limitations include insufficient follow-up to report on the 5-year recurrence probability and inability to adjust for confounding factors beyond histology. This data implies that IGSRT is a well-tolerated, paradigm-shifting treatment option for patients with early stage NMSCs who cannot tolerate or refuse surgery. IGSRT provides patients the choice of treatment modality that best aligns with their goals of care.

 Pubmed Scholar sci-hub

Int J Radiat Oncol Biol Phys 01 Oct. 2023.
Efficacy of Single-Fraction Postoperative Radiotherapy in Resected, Early-Stage Merkel Cell Carcinoma with High-Risk Features.

SF-PORT is associated with a very low LRR which has proven durable with long-term follow-up. The LRR for SF-PORT appears lower than historical controls treated with surgery alone for patients with resected, stage I/II MCC with high-risk features.

 Pubmed Scholar sci-hub

Int J Radiat Oncol Biol Phys 01 Oct. 2023.
Radiation Therapy Generates Release of Microvesicle Particles in Keratinocytes.

The present studies indicate that RT can generates MVP production in epithelial cells. The mechanism for IR-generated MVP appears to involve aSMase and the PAFR. Target cell MVP release may provide a mechanism for RT effects, including the release of cytokines that influence systemic and local inflammation. Elucidation of this novel pathway may provide insights into IR effects on skin along with new therapeutic strategies.

 Pubmed Scholar sci-hub

Int J Radiat Oncol Biol Phys 01 Oct. 2023.
Risk-Stratification using the 40-Gene Expression Profile (40-GEP) Test Identifies Patients with Node Negative Cutaneous Squamous Cell Carcinoma (cSCC) at Higher Risk of Metastasis Who May Benefit from Adjuvant Radiation Therapy (ART).

Within this eligible for ART population, patients with Class 2A or 2B 40-GEP results have inferior rates of MFS, while Class 1 patients have <10% risk of metastasis. Nearly half of this population received a 40-GEP Class 1 result and could be considered for treatment de-intensification trials. Conversely, patients with low-risk BWH T1 stage, who are traditionally not considered for ART, that received a Class 2A or 2B (>10% risk of metastasis) could be considered for adjuvant therapy.

 Pubmed Scholar sci-hub

BMC Ophthalmol 02 Oct. 2023.
Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study.

The grade of disability is related to their VR-QoL assessment using the NEI-VFQ-25 questionnaire. Thus, it can be used as an initial screening in primary healthcare settings to increase awareness of disability before a thorough physical examination.

 Pubmed Scholar sci-hub

Am J Case Rep 02 Oct. 2023.
Successful Management of Angioinvasive Deep Fungal Infections of the Penis: A Multidisciplinary Approach with Intraoperative Frozen Margins.

This includes treatment of the underlying immunocompromising condition, appropriate intravenous antifungal therapy, and urgent operative debridement. This report highlights the importance of utilizing intraoperative frozen sections to ensure negative margins and to optimize overall tissue sparing in this anatomically sensitive area

 Pubmed Scholar sci-hub

Paediatr Drugs 02 Oct. 2023.
Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options.

On this basis, there exist several pharmacological modalities in the treatment of children and adolescents with HS including topical therapies, systemic therapies, and biologics. The goals of this review article are to: (1) review the efficacy of different pharmacological treatment modalities in children and adolescents with HS, and (2) review the safety and monitoring considerations of the different treatment options in children and adolescents with HS

 Pubmed Scholar sci-hub

Dermatitis 29 Sep. 2023.
Stasis Dermatitis: The Burden of Disease, Diagnosis, and Treatment.

Sorry! No treatment pearl could be fetched.

 Pubmed Scholar sci-hub

J Dermatolog Treat Dec. 2023.
High-fluence 1064nm Q-switched Nd:YAG laser treatment for ectopic Mongolian spot.

4) groups.High-fluence Q-switched Nd:YAG laser without tissue whitening showed good results and was well-tolerated in treating ectopic Mongolian spots

 Pubmed Scholar sci-hub

J Dermatolog Treat Dec. 2023.
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.

Among biologics included in these two NMAs, ixekizumab has the highest absolute probability of achieving complete resolution of NP. Results may help to inform treatment decisions for patients with NP.

 Pubmed Scholar sci-hub

Int Clin Psychopharmacol 02 Oct. 2023.
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?

008). Patients with AD treated for one year with dupilumab showed a better mental health profile in terms of less severe anxiety and depression with respect to their counterparts

 Pubmed Scholar sci-hub